ABT-869 : Results of a phase 1, randomized study evaluating the effects of food and diurnal variation on the pharmacokinetics of linifanib

Dihydroartemisinin : Synergistic integration of dihydro-artemisinin with γ-aminobutyric acid results in a more potential anti-depressant